184 related articles for article (PubMed ID: 22466864)
1. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: pathobiological mechanisms and clinical implications.
Menéndez ST; Villaronga MA; Rodrigo JP; Alvarez-Teijeiro S; García-Carracedo D; Urdinguio RG; Fraga MF; Pardo LA; Viloria CG; Suárez C; García-Pedrero JM
J Mol Med (Berl); 2012 Oct; 90(10):1173-84. PubMed ID: 22466864
[TBL] [Abstract][Full Text] [Related]
2. Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.
Menéndez ST; Rodrigo JP; Alvarez-Teijeiro S; Villaronga MÁ; Allonca E; Vallina A; Astudillo A; Barros F; Suárez C; García-Pedrero JM
Mod Pathol; 2012 Aug; 25(8):1069-78. PubMed ID: 22460808
[TBL] [Abstract][Full Text] [Related]
3. HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms.
Menéndez ST; Villaronga MÁ; Rodrigo JP; Álvarez-Teijeiro S; Urdinguio RG; Fraga MF; Suárez C; García-Pedrero JM
Sci Rep; 2016 Jan; 6():19666. PubMed ID: 26785772
[TBL] [Abstract][Full Text] [Related]
4. Human ether à-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry.
Hammadi M; Chopin V; Matifat F; Dhennin-Duthille I; Chasseraud M; Sevestre H; Ouadid-Ahidouch H
J Cell Physiol; 2012 Dec; 227(12):3837-46. PubMed ID: 22495877
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of potassium channel ether à go-go in human osteosarcoma.
Wu J; Wu X; Lian K; Lin B; Guo L; Ding Z
Neoplasma; 2012; 59(2):207-15. PubMed ID: 22248279
[TBL] [Abstract][Full Text] [Related]
6. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
7. The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia.
Agarwal JR; Griesinger F; Stühmer W; Pardo LA
Mol Cancer; 2010 Jan; 9():18. PubMed ID: 20105281
[TBL] [Abstract][Full Text] [Related]
8. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
9. Human ether-à-go-go gene potassium channels are regulated by EGFR tyrosine kinase.
Wu W; Dong MQ; Wu XG; Sun HY; Tse HF; Lau CP; Li GR
Biochim Biophys Acta; 2012 Feb; 1823(2):282-9. PubMed ID: 22061963
[TBL] [Abstract][Full Text] [Related]
10. A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells.
Cázares-Ordoñez V; González-Duarte RJ; Díaz L; Ishizawa M; Uno S; Ortíz V; Ordoñez-Sánchez ML; Makishima M; Larrea F; Avila E
Biochem Cell Biol; 2015 Feb; 93(1):94-101. PubMed ID: 25495694
[TBL] [Abstract][Full Text] [Related]
11. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells.
Zhang YY; Yue J; Che H; Sun HY; Tse HF; Li GR
J Cell Physiol; 2014 Feb; 229(2):202-12. PubMed ID: 23881642
[TBL] [Abstract][Full Text] [Related]
12. Long-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.
Pier DM; Shehatou GS; Giblett S; Pullar CE; Trezise DJ; Pritchard CA; Challiss RA; Mitcheson JS
Mol Pharmacol; 2014 Aug; 86(2):211-21. PubMed ID: 24830940
[TBL] [Abstract][Full Text] [Related]
13. Corydaline binds to a druggable pocket of hEAG1 channel and inhibits hepatic carcinoma cell viability.
Ma B; Shi S; Ren S; Qu C; Zhao Z; An H
Eur J Pharmacol; 2024 Jan; 962():176240. PubMed ID: 38048981
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IGF-1-dependent cyclin D1 and E expression by hEag1 channels in MCF-7 cells: the critical role of hEag1 channels in G1 phase progression.
Borowiec AS; Hague F; Gouilleux-Gruart V; Lassoued K; Ouadid-Ahidouch H
Biochim Biophys Acta; 2011 May; 1813(5):723-30. PubMed ID: 21315112
[TBL] [Abstract][Full Text] [Related]
15. HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma.
Fernández-Valle Á; Rodrigo JP; Rodríguez-Santamarta T; Villaronga MÁ; Álvarez-Teijeiro S; García-Pedrero JM; Suárez-Fernández L; Lequerica-Fernández P; de Vicente JC
Head Neck; 2016 Nov; 38(11):1672-1678. PubMed ID: 27131339
[TBL] [Abstract][Full Text] [Related]
16. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
17. Activation of hEAG1 potassium channels by arachidonic acid.
Gavrilova-Ruch O; Schönherr R; Heinemann SH
Pflugers Arch; 2007 Mar; 453(6):891-903. PubMed ID: 17120019
[TBL] [Abstract][Full Text] [Related]
18. Novel venom-derived inhibitors of the human EAG channel, a putative antiepileptic drug target.
Ma L; Chin YKY; Dekan Z; Herzig V; Chow CY; Heighway J; Lam SW; Guillemin GJ; Alewood PF; King GF
Biochem Pharmacol; 2018 Dec; 158():60-72. PubMed ID: 30149017
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin.
Schönherr R; Löber K; Heinemann SH
EMBO J; 2000 Jul; 19(13):3263-71. PubMed ID: 10880439
[TBL] [Abstract][Full Text] [Related]
20. Estrogens and human papilloma virus oncogenes regulate human ether-à-go-go-1 potassium channel expression.
Díaz L; Ceja-Ochoa I; Restrepo-Angulo I; Larrea F; Avila-Chávez E; García-Becerra R; Borja-Cacho E; Barrera D; Ahumada E; Gariglio P; Alvarez-Rios E; Ocadiz-Delgado R; Garcia-Villa E; Hernández-Gallegos E; Camacho-Arroyo I; Morales A; Ordaz-Rosado D; García-Latorre E; Escamilla J; Sánchez-Peña LC; Saqui-Salces M; Gamboa-Dominguez A; Vera E; Uribe-Ramírez M; Murbartián J; Ortiz CS; Rivera-Guevara C; De Vizcaya-Ruiz A; Camacho J
Cancer Res; 2009 Apr; 69(8):3300-7. PubMed ID: 19351862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
